Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stiefel, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stiefel, L.

Erythema Infectiosum (Fifth Disease)

Laurence Stiefel MD1
1 Elmhurst Hospital Center, Mt. Sinai Medical Center, New York, NY

Erythema infectiosum (EI), also known as fifth disease, is one of the most common childhood exanthems. The condition first was described by Tschamer in 1889 and initially was thought to be a manifestation of rubella. It is seen most often in children ages 4 to 15 years and has peak incidences in winter and spring. It can present in focal outbreaks or in community-wide epidemics, which can last from 3 to 6 months. Infection rates of 20% to 50% have been noted in families and classrooms.

The condition was termed fifth disease because of the numerical designation it originally was given (following measles, scarlet fever, rubella, and Filatov-Dukes disease, now regarded as a mild atypical form of scarlet fever).




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
T. C. Harder, M. Hufnagel, K. Zahn, K. Beutel, H.-J. Schmitt, U. Ullmann, and P. Rautenberg
New LightCycler PCR for Rapid and Sensitive Quantification of Parvovirus B19 DNA Guides Therapeutic Decision-Making in Relapsing Infections
J. Clin. Microbiol., December 1, 2001; 39(12): 4413 - 4419.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1995 by the American Academy of Pediatrics.